#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuromyelitis optica spectrum disorder Solitary fibrous tumour Oesophageal atresia Biliary neoplasm Fatty acid oxidation disorder Cerebellar ataxia Lung adenocarcinoma Focal segmental glomerulosclerosis Glioblastoma multiforme Ovarian cancer stage IV Sarcoma Endometrial cancer recurrent Homocystinuria Obesity Cystic fibrosis lung More trials…

    Learn about Rare Diseases

    Langerhans’ cell histiocytosis – Treatment Tuberous sclerosis complex – Treatment Nodal marginal zone B-cell lymphoma – Basic Information KBG syndrome – Life with Disease Adrenocortical carcinoma Adrenocortical carcinoma – Treatment Epidermolysis bullosa – Trials in Disease Soft tissue sarcoma – Trials in Disease Mucopolysaccharidosis III Myelodysplastic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lisaftoclax 12 Grass Pollen Mixture Star-0215 Daptomycin Insulin Lispro Human Immunoglobulin G Warfarin Sodium Taplucainium Chloride Degarelix Acetate Paracetamol Dc Sulodexide GSK5764227 HLX43 Amlodipine Besilate Cobamamide Colecalciferol TEDUGLUTIDE Ethinylestradiol Molgramostim Abc-23A-116 More therapies…

    Learn about Your Condition

    Diabetic retinal oedema Heart transplant Neuralgia Astrocytoma malignant Osteoarthritis Endometrial cancer Diabetes insipidus Juvenile spondyloarthritis Osteonecrosis of jaw Adrenogenital syndrome Biliary cancer metastatic Triple negative breast cancer Mixed dementia Behavioural addiction Mantle cell lymphoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Seizure

  • Study of Pyridoxal Phosphate for Treatment of Seizures in Patients with PNPO Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Seizure
    Poland

  • Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

    Recruiting

    3 1
    Investigated Drugs:
    • Alprazolam
    Bulgaria Czechia France Germany Hungary Italy +2

  • Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

    Recruiting

    3 1
    Investigated Drugs:
    • Alprazolam
    Bulgaria Czechia Germany Hungary Italy Poland +1

  • Study on the Effects of Psilocybin for Patients with Psychogenic Non-Epileptic Seizures (PNES)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Psychogenic seizure
    • Seizure
    Investigated Drugs:
    • Psilocybine
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!